Company Management

FoRx Therapeutics

Biotechnology Research Basel, Basel-stadt, Ch 34 employees

Employees: 34
Contacts: 3
Emails: 3
Phones: 1

forxtherapeutics.com LinkedIn Crunchbase

FoRx Therapeutics Overview

Headquarters: Basel, Basel-stadt, Ch
Website: forxtherapeutics.com
Industry: Biotechnology Research
Employees: 34
Founded: 2019
Funding: 10.8M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Representative jobs

About FoRx Therapeutics

FoRx Therapeutics is a recently incorporated privately-held company based in Basel, Switzerland. It is backed by a syndicate of investors that include the Novartis Venture Fund, Pfizer Ventures, M Ventures, Omega Funds and LSP Venture Capital. FoRx Therapeutics focuses on drugging key molecular targets involved in the DNA Replication Stress, as a new approach in the development of targeted anticancer drugs.

FoRx Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

FoRx Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Michael Kauffman	Drug Developer, Board Member, Physician Scientist	North Miami Beach, Florida, United States	Email Phone
Nicolas Bocquet	Director-head of Protein Sciences (Small Molecules - Biochemistry - Biophysics - Structural Biology) Chez Forx Therapeutics	Basel, Switzerland	Email
Nadiya Ishnazarova	Principal at M Ventures, Biotechnology Investments - Phd Biochemistry and Genetics		View
Frank Zenke	Cso at Forx Therapeutics	Basel, Switzerland	Email